InMed Pharmaceuticals Inc (INM)
0.2632
-0.01
(-4.05%)
USD |
NASDAQ |
May 10, 16:00
0.2632
0.00 (0.00%)
After-Hours: 18:54
InMed Pharmaceuticals Cash from Financing (Quarterly): 4.654M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.654M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -0.0637M |
| December 31, 2022 | 5.315M |
| September 30, 2022 | 5.429M |
| June 30, 2022 | 5.051M |
| March 31, 2022 | -0.0293M |
| December 31, 2021 | -0.8361M |
| September 30, 2021 | 10.88M |
| June 30, 2021 | -0.0832M |
| March 31, 2021 | 4.045M |
| December 31, 2020 | 6.958M |
| September 30, 2020 | -0.0646M |
| June 30, 2020 | -0.031M |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.054M |
| March 31, 2019 | 0.1453M |
| December 31, 2018 | -0.0004M |
| September 30, 2018 | 0.0087M |
| June 30, 2018 | 10.46M |
| March 31, 2018 | 1.262M |
| December 31, 2017 | 6.345M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.5473M |
| June 30, 2017 | 3.94M |
| March 31, 2017 | 2.270M |
| December 31, 2016 | 1.040M |
| September 30, 2016 | 0.2513M |
| June 30, 2016 | 0.1021M |
| March 31, 2016 | 0.0552M |
| December 31, 2015 | 0.1346M |
| September 30, 2015 | 0.0083M |
| June 30, 2015 | 0.8534M |
| March 31, 2015 | 0.6698M |
| December 31, 2014 | 0.1133M |
| September 30, 2014 | 0.1039M |
| June 30, 2014 | 0.6464M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.8361M
Minimum
Dec 2021
10.88M
Maximum
Sep 2021
2.294M
Average
--
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| Rimrock Gold Corp | 0.0449M |
| Venus Concept Inc | 1.271M |
| Juva Life Inc | -0.0204M |
| CEN Biotech Inc | 0.00 |
| Lucy Scientific Discovery Inc | 0.757M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.848M |
| Cash from Investing (Quarterly) | -0.0093M |
| Free Cash Flow | -6.508M |
| Free Cash Flow Per Share (Quarterly) | -0.233 |
| Free Cash Flow to Equity (Quarterly) | -1.857M |
| Free Cash Flow to Firm (Quarterly) | -1.857M |
| Free Cash Flow Yield | -550.9% |